Search

Your search keyword '"PESCI, ALBERTO"' showing total 659 results

Search Constraints

Start Over You searched for: Author "PESCI, ALBERTO" Remove constraint Author: "PESCI, ALBERTO"
659 results on '"PESCI, ALBERTO"'

Search Results

2. Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study

3. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

6. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

7. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

8. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

9. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

10. Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study

11. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study

12. Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach

13. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

14. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

16. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

17. Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study

18. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy

19. Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis

20. Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia

21. Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak

23. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

24. Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis

25. Short-term evolution of nutritional status in patients with idiopathic pulmonary fibrosis

26. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

27. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia

29. Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis

31. Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis

32. Characterization of bronchiectasis in the elderly

34. Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation)

35. Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy

36. Additional file 2 of Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study

37. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

38. Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study

41. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

43. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

44. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

45. Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres

46. Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study

47. Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF):an open-label extension study

48. Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach

49. Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy

50. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study

Catalog

Books, media, physical & digital resources